SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-17-164257
Filing Date
2017-05-09
Accepted
2017-05-09 16:30:51
Documents
53
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d188131d10q.htm 10-Q 554495
2 EX-31.1 d188131dex311.htm EX-31.1 8850
3 EX-31.2 d188131dex312.htm EX-31.2 8845
4 EX-32.1 d188131dex321.htm EX-32.1 5428
  Complete submission text file 0001193125-17-164257.txt   2473485

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT zfgn-20170331.xml EX-101.INS 392516
6 XBRL TAXONOMY EXTENSION SCHEMA zfgn-20170331.xsd EX-101.SCH 31351
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE zfgn-20170331_cal.xml EX-101.CAL 48677
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE zfgn-20170331_def.xml EX-101.DEF 76744
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE zfgn-20170331_lab.xml EX-101.LAB 232393
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE zfgn-20170331_pre.xml EX-101.PRE 158154
Mailing Address 175 PORTLAND STREET 4TH FLOOR BOSTON MA 02114
Business Address 175 PORTLAND STREET 4TH FLOOR BOSTON MA 02114 617-622-4003
ZAFGEN, INC. (Filer) CIK: 0001374690 (see all company filings)

IRS No.: 203857670 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36510 | Film No.: 17826878
SIC: 2834 Pharmaceutical Preparations